Notably, even variable-onset disorders (e.g., COL3A1-related vEDS) demand early surveillance when genetic testing identifies high-risk youth, underscoring the need for age-adapted management protocols. This evidence concerns the gene COL3A1 and Ehlers-Danlos syndrome, vascular type.